Lung Cancer Treatment

Lung cancer Treatment,medical therapies,

such as surgery, radiation, chemotherapy, and palliative care,

alone, or in combination, in an attempt to cure or lessen the

lung cancer.

In recent years, various molecular,targeted therapies, have been

developed, for the treatment, of advanced lung cancer.

Gefitinib (Iressa) is one such drug, which targets the tyrosine

kinase domain, of the epidermal growth factor receptor (EGFR),

expressed in many cases, of non-small cell lung cancer.

Sushi Chef kit Making

Chemotherapy

For clinical and treatment purposes, most oncologists tend to

classify lung cancer into two major groups, namely small cell

lung cancer(SCLC) and non-small cell lung cancer (NSCLC).

This is done because of differing responses to treatment -

non-small-cell-cancer is comparatively less sensitive to

chemotherapy and/or radiation,

so surgery is the treatment of choice in these tumors.

small-cell-cancer, in contrast, usually initially responds well

Spread

to chemotherapy and/or radiation, but has usually

metastasized,(spread), widely by the time it is discovered,

making surgery ineffective.

It is estimated, that approximately, 80% of cancer patients,

in the U.S. have non-small cell cancer. (NSCLC),

while approximately, 15%, have small cell cancer (SCLC).

non-small cell cancer

It is estimated, that approximately, 80% of cancer patients, in

the U.S. have non-small cell cancer. (NSCLC),

while approximately, 15%, have small cell cancer (SCLC).

Patients diagnosed, with cancers, in these two groups are

treated,in most cases, according to guidelines

derived, and published, by consensus of expert panels after

review of clinical trial and meta-analytic data,

treatment, that recognizes, and incorporates, newly

discovered associations between particular histologic subtypes

of cancer, and molecular, oncogenetic, mutations, and pathways,

helping to drive, their malignant, phenotypes.